Communicable

Communicable takes on hot topics in infectious diseases and clinical microbiology. Hosted by the editors of CMI Communications, the open-access journal of ESCMID, the European Society of Clinical Microbiology & Infectious Diseases.

More
Recent Episodes
  • Communicable E26: SNAP out of it: Rethinking anti-staphylococcal penicillins for S. aureus bacteremia - the SNAP trial PSSA/MSSA results
    May 5, 2025 – 01:10:50
  • Communicable E25: The Nightmare Series, part 5 - Measles is back
    Apr 21, 2025 – 55:27
  • Communicable E24: The role of medical societies in global health - An interview with ESCMID leadership
    Apr 7, 2025 – 47:50
  • Communicable E23: Women & men in medicine: An honest discussion, part 2
    Mar 24, 2025 – 31:24
  • Communicable E22: Women & men in medicine: An honest discussion, part 1
    Mar 8, 2025 – 40:17
  • Communicable E21: FMT for C. difficile infections - does it work?
    Feb 24, 2025 – 56:32
  • Communicable E20: Tuberculosis today
    Feb 10, 2025 – 54:18
  • Communicable E19: ‘Super gonorrhoea’ & other sexually transmitted infections
    Jan 27, 2025 – 58:15
  • Communicable E18: The Nightmare Series, part 4 - How to manage polio and rubella
    Jan 13, 2025 – 59:47
  • Communicable E17: Season’s greetings from the editors & holiday replay of late-breaker clinical trials at ESCMID Global 2024
    Dec 30, 2024 – 01:04:39
  • Communicable E16: Climate change and infections – effects on clinical practice & infection-control efforts
    Dec 16, 2024 – 50:46
  • Communicable E15: Wastewater surveillance – can it really protect us from infections?
    Dec 2, 2024 – 54:59
  • Communicable E14 - Substandard and falsified antimicrobials: what is their effect on patients and on AMR?
    Nov 18, 2024 – 52:00
  • Communicable E13 - The Wild West of publishing today: predatory journals and how to deal with them
    Nov 4, 2024 – 46:22
  • Communicable E12 - The Nightmare Series, part 3: How to deal with vancomycin-resistant enterococci
    Oct 21, 2024 – 57:01
  • Communicable E11 - Nightmare series, part 2: How to deal with carbapenemase producers
    Oct 7, 2024 – 01:00:22
  • Communicable E10 - Pipeline update: new antibiotics & other antimicrobials that you might actually use
    Sep 23, 2024 – 52:37
  • Communicable E9 - Avian flu: an update
    Sep 9, 2024 – 50:25
  • Communicable E8 - The Nightmare Series, part 1: How to deal with Candida auris
    Aug 26, 2024 – 59:24
  • Communicable E7 - Melioidosis goes global
    Aug 12, 2024 – 52:08
  • Communicable E6 - “Sneaky viruses”: an update on hepatitis B & C before World Hepatitis Day
    Jul 25, 2024 – 54:06
  • Communicable E5 - Beauty is in the 'I' of the beholder: EUCAST updates
    Jul 15, 2024 – 38:31
  • Communicable E4 - The BLING-3 trial & continuous beta-lactam infusion: should these results change your practice?
    Jul 1, 2024 – 44:52
  • Communicable E3 - The new WHO Priority Pathogens List: which bugs to target first?
    Jun 17, 2024 – 42:58
  • Communicable E2 - Phage therapy: does it work and will we have access?
    Jun 3, 2024 – 54:00
  • Communicable E1 - Late-breaker clinical trial results from ESCMID Global 2024: Should they change your practice?
    May 10, 2024 – 58:02
Recent Reviews
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.